Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Meet Our Editor-in-Chief
Volume: 18 Issue: 1
Author(s): Ryuichi Morishita
Affiliation:
Export Options
About this article
Cite this article as:
Morishita Ryuichi , Meet Our Editor-in-Chief, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2018; 18 (1) . https://dx.doi.org/10.2174/187152221801180905151147
DOI https://dx.doi.org/10.2174/187152221801180905151147 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
24
2
2
Related Articles
-
Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders
Current Pharmaceutical Biotechnology Advancements in the Anti-Diabetes Chemotherapeutics Based on Amino Acids, Peptides, and Peptidomimetics
Mini-Reviews in Medicinal Chemistry Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety
Current Medicinal Chemistry Atrial Remodeling and Novel Pharmacological Strategies for Antiarrhythmic Therapy in Atrial Fibrillation
Current Medicinal Chemistry An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus
Current Diabetes Reviews Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Drug Targets NPY Y2 and Y4 Receptors Selective Ligands: Promising Anti-Obesity Drugs?
Current Topics in Medicinal Chemistry Molecular Docking Simulations as a Prominent Tool to Envisage the Preformulation Perspectives of Oral Hypoglycaemic Agents with β-cyclodextrin
Letters in Drug Design & Discovery Role of Quality Management System (QMS) for Effective Regulatory Compliance
Applied Clinical Research, Clinical Trials and Regulatory Affairs Meet Our Editorial Board Member:
Current Medicinal Chemistry Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
CNS & Neurological Disorders - Drug Targets Aurones as New Porcine Pancreatic α-Amylase Inhibitors
Letters in Drug Design & Discovery miR-126 as a Therapeutic Agent for Diabetes Mellitus
Current Pharmaceutical Design Reduction of Hepatic Glucose Production as a Therapeutic Target in the Treatment of Diabetes
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Angina in Women without Obstructive Coronary Artery Disease
Current Cardiology Reviews New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Bitter Gourd (Momordica charantia) is a Cornucopia of Health: A Review of its Credited Antidiabetic, Anti-HIV, and Antitumor Properties
Current Molecular Medicine Infrequent Infections in COPD
Current Respiratory Medicine Reviews New Perspectives on Machine Learning in Drug Discovery
Current Medicinal Chemistry